PSI Advisors’s Medifast MED Stock Holding History

PSI Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45	Closed	-$607	–	446
2025 Q1	$607	Hold	45	–	–	﹤0.01%	674
2024 Q4	$793	Hold	45	–	–	﹤0.01%	794
2024 Q3	$861	Hold	45	–	–	﹤0.01%	789
2024 Q2	$982	Hold	45	–	–	﹤0.01%	760
2024 Q1	$1.72K	Sell	45 -9	-17%	-$436	﹤0.01%	670
2023 Q4	$3.63K	Hold	54	–	–	﹤0.01%	665
2023 Q3	$4.04K	Hold	54	–	–	﹤0.01%	619
2023 Q2	$4.98K	Buy	54 +9	+20%	+$801	﹤0.01%	588
2023 Q1	$4.67K	Hold	45	–	–	﹤0.01%	542
2022 Q4	$5.19K	Hold	45	–	–	﹤0.01%	507
2022 Q3	$5K	Sell	45 -45	-50%	-$6.45K	﹤0.01%	526
2022 Q2	$16K	Hold	90	–	–	0.01%	384
2022 Q1	$15K	Hold	90	–	–	0.01%	407
2021 Q4	$19K	Hold	90	–	–	0.01%	404
2021 Q3	$17K	Buy	+90	New	+$22.1K	0.01%	411
2020 Q1	–	Sell	-90	Closed	-$9K	–	389
2019 Q4	$9K	Buy	+90	New	+$8.71K	0.01%	481

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PSI Advisors's MED Position: Q2 2025 in Review

PSI Advisors sold out of Medifast (MED) in Q2 2025, closing a stake of 45 shares — an estimated $607 sold.

PSI Advisors first reported a position in MED in Q4 2019 and held it in 16 quarters. The position peaked at $19K in Q4 2021. 120 funds tracked by Wall St. Rank hold MED as of Q2 2025.

PSI Advisors reported no remaining Medifast position as of Q2 2025 after selling out during the quarter.
PSI Advisors sold 45 Medifast shares in Q2 2025, an estimated $607.
PSI Advisors first reported a position in Medifast in Q4 2019 and held it in 16 quarters.
PSI Advisors's Medifast position peaked at $19K in Q4 2021.
120 funds tracked by Wall St. Rank held Medifast as of Q2 2025.

Based on PSI Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.